IMVT Immunovant, Inc.
Nasdaq · SEC CIK 1764013 · EDGAR
- Bought, last 12 months
- $350.00M 1 purchases by 1 insiders
- Sold, last 12 months
- $15.93M 38 sales by 10 insiders
- Filings on record
- 265 since 2021-08-02, latest 2026-08-28 16:27
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Roivant Sciences Ltd. | Dir, 10% | $350.00M | — |
| Fromkin Andrew J. | Dir | — | $7.96M |
| Stout Jay S | CTO | — | $2.27M |
| Gloria Melanie | COO | — | $1.60M |
| Girao Tiago | CFO | — | $1.41M |
| Van Tuyl Christopher | CLO | — | $1.31M |
| Venker Eric | CEO, Dir | — | $461.8K |
| Pande Atul | Dir | — | $424.6K |
| Hughes Douglas J. | Dir | — | $348.7K |
| Geffner Michael | Chief Medical Off | — | $70.1K |
Transactions 274
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-26 | 2023-04-25 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $16.29 | -509 | 350.2K | -0.1% | -$8,292 | |
| D | 2023-04-19 | 2023-04-17 | IMVT | Stout Jay S | CTO | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
| 2023-04-19 | 2023-04-18 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $15.27 | -3,395 | 1.23M | -0.3% | -$51.8K | |
| 2023-04-19 | 2023-04-18 | IMVT | Barnett Eva Renee | CFO | S - Sale | $15.27 | -3,423 | 352.6K | -1.0% | -$52.3K | |
| 2023-04-19 | 2023-04-18 | IMVT | Butchko Julia G. | Chief Development Off | S - Sale | $15.27 | -1,544 | 430.1K | -0.4% | -$23.6K | |
| D | 2023-04-14 | 2023-04-12 | IMVT | Torti Frank | Dir | A - Grant | $0.00 | +121.9K | 515.3K | +31% | $0 |
| D | 2023-04-14 | 2023-04-12 | IMVT | Levine Mark S. | CLO | A - Grant | $0.00 | +87.7K | 333.3K | +36% | $0 |
| D | 2023-04-14 | 2023-04-12 | IMVT | Butchko Julia G. | Chief Dev, Tech. Off | A - Grant | $0.00 | +100.2K | 431.6K | +30% | $0 |
| D | 2023-04-14 | 2023-04-12 | IMVT | Fromkin Andrew J. | Dir | A - Grant | $0.00 | +12.5K | 101.0K | +14% | $0 |
| D | 2023-04-14 | 2023-04-12 | IMVT | MIGAUSKY GEORGE V | Dir | A - Grant | $0.00 | +12.5K | 122.5K | +11% | $0 |
| D | 2023-04-14 | 2023-04-12 | IMVT | Macias William L. | Chief Medical Off | A - Grant | $0.00 | +87.7K | 350.7K | +33% | $0 |
| D | 2023-04-14 | 2023-04-12 | IMVT | Hughes Douglas J. | Dir | A - Grant | $0.00 | +12.5K | 113.8K | +12% | $0 |
| D | 2023-04-14 | 2023-04-12 | IMVT | Salzmann Peter | CEO, Dir | A - Grant | $0.00 | +243.8K | 1.24M | +25% | $0 |
| D | 2023-04-14 | 2023-04-12 | IMVT | Barnett Eva Renee | CFO | A - Grant | $0.00 | +87.7K | 356.0K | +33% | $0 |
| D | 2023-04-14 | 2023-04-12 | IMVT | Pande Atul | Dir | A - Grant | $0.00 | +12.5K | 95.5K | +15% | $0 |
| 2023-02-03 | 2023-02-02 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $18.24 | -537 | 263.0K | -0.2% | -$9,795 | |
| 2023-01-27 | 2023-01-26 | IMVT | Levine Mark S. | CLO | S - Sale | $18.51 | -10.2K | 245.7K | -4% | -$188.0K | |
| M | 2023-01-13 | 2023-01-11 | IMVT | Barnett Eva Renee | CFO | S - Sale | $16.75 | -4,510 | 272.8K | -2% | -$75.5K |
| M | 2023-01-13 | 2023-01-11 | IMVT | Butchko Julia G. | Chief Dev, Tech. Off | S - Sale | $16.79 | -60.5K | 331.4K | -15% | -$1.02M |
| 2023-01-13 | 2023-01-11 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $16.80 | -4,021 | 993.9K | -0.4% | -$67.6K | |
| M | 2023-01-13 | 2023-01-11 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $16.75 | -44.6K | 263.5K | -14% | -$746.3K |
| 2022-10-25 | 2022-10-21 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $9.67 | -341 | 308.1K | -0.1% | -$3,297 | |
| 2022-10-17 | 2022-10-13 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $9.18 | -2,793 | 998.0K | -0.3% | -$25.6K | |
| 2022-10-17 | 2022-10-13 | IMVT | Butchko Julia G. | Chief Dev, Tech. Off | S - Sale | $9.18 | -928 | 391.9K | -0.2% | -$8,519 | |
| 2022-10-13 | 2022-10-11 | IMVT | Barnett Eva Renee | CFO | S - Sale | $9.44 | -12.5K | 272.9K | -4% | -$118.0K | |
| 2022-10-07 | 2022-10-06 | IMVT | Roivant Sciences Ltd. | 10% | P - Purchase | $6.00 | +416.7K | 73.81M | +0.6% | +$2.50M | |
| I | 2022-10-04 | 2022-09-30 | IMVT | Pande Atul | Dir | P - Purchase | $5.60 | +15.0K | 20.0K | +300% | +$84.0K |
| 2022-09-29 | 2022-09-28 | IMVT | Butchko Julia G. | Chief Dev, Tech. Off | S - Sale | $4.67 | -535 | 392.8K | -0.1% | -$2,498 | |
| 2022-09-29 | 2022-09-29 | IMVT | Torti Frank | Dir | P - Purchase | $5.81 | +20.0K | 393.4K | +5% | +$116.2K | |
| 2022-09-29 | 2022-09-28 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $4.67 | -1,605 | 1.00M | -0.2% | -$7,495 | |
| 2022-09-01 | 2022-08-30 | IMVT | Butchko Julia G. | Chief Dev, Tech. Off | S - Sale | $5.83 | -548 | 393.4K | -0.1% | -$3,195 | |
| 2022-09-01 | 2022-08-30 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $5.83 | -1,644 | 1.00M | -0.2% | -$9,585 | |
| D | 2022-08-19 | 2022-08-17 | IMVT | Torti Frank | Dir | A - Grant | $0.00 | +225.6K | 373.4K | +153% | $0 |
| D | 2022-08-19 | 2022-08-17 | IMVT | Hughes Douglas J. | Dir | A - Grant | $0.00 | +21.1K | 101.2K | +26% | $0 |
| D | 2022-08-19 | 2022-08-17 | IMVT | Barnett Eva Renee | CFO | A - Grant | $0.00 | +112.8K | 285.4K | +65% | $0 |
| D | 2022-08-19 | 2022-08-17 | IMVT | Pande Atul | Dir | A - Grant | $0.00 | +21.1K | 83.0K | +34% | $0 |
| D | 2022-08-19 | 2022-08-17 | IMVT | Levine Mark S. | CLO | A - Grant | $0.00 | +112.8K | 255.8K | +79% | $0 |
| D | 2022-08-19 | 2022-08-17 | IMVT | MIGAUSKY GEORGE V | Dir | A - Grant | $0.00 | +21.1K | 110.0K | +24% | $0 |
| D | 2022-08-19 | 2022-08-17 | IMVT | Macias William L. | Chief Medical Off | A - Grant | $0.00 | +112.8K | 308.4K | +58% | $0 |
| D | 2022-08-19 | 2022-08-17 | IMVT | Salzmann Peter | CEO, Dir | A - Grant | $0.00 | +451.3K | 1.00M | +82% | $0 |
| D | 2022-08-19 | 2022-08-17 | IMVT | Fromkin Andrew J. | Dir | A - Grant | $0.00 | +21.1K | 88.5K | +31% | $0 |
| D | 2022-08-19 | 2022-08-17 | IMVT | Butchko Julia G. | Chief Dev, Tech. Off | A - Grant | $0.00 | +112.8K | 393.9K | +40% | $0 |
| 2022-07-29 | 2022-07-27 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $4.27 | -1,528 | 552.7K | -0.3% | -$6,525 | |
| 2022-07-29 | 2022-07-27 | IMVT | Butchko Julia G. | Chief Dev, Tech. Off | S - Sale | $4.27 | -510 | 281.1K | -0.2% | -$2,178 | |
| 2022-07-26 | 2022-07-22 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $4.70 | -322 | 195.6K | -0.2% | -$1,513 | |
| 2022-07-01 | 2022-06-29 | IMVT | Butchko Julia G. | Chief Dev, Tech. Off | S - Sale | $4.02 | -460 | 281.6K | -0.2% | -$1,849 | |
| 2022-07-01 | 2022-06-29 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $4.02 | -1,376 | 554.3K | -0.2% | -$5,532 | |
| 2022-05-25 | 2022-05-24 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $3.79 | -1,471 | 555.6K | -0.3% | -$5,575 | |
| 2022-05-25 | 2022-05-24 | IMVT | Butchko Julia G. | Chief Dev, Tech. Off | S - Sale | $3.79 | -492 | 282.1K | -0.2% | -$1,865 | |
| 2022-04-29 | 2022-04-27 | IMVT | Butchko Julia G. | Chief Dev, Tech. Off | S - Sale | $4.72 | -541 | 282.6K | -0.2% | -$2,554 | |
| 2022-04-29 | 2022-04-27 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $4.72 | -1,622 | 557.1K | -0.3% | -$7,656 | |
| 2022-04-20 | 2022-04-19 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $4.98 | -1,392 | 195.9K | -0.7% | -$6,932 | |
| 2022-04-14 | 2022-03-24 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $5.90 | -19.2K | 558.7K | -3% | -$113.4K | |
| 2022-04-14 | 2022-03-24 | IMVT | Butchko Julia G. | Chief Dev, Tech. Off | S - Sale | $5.90 | -6,381 | 283.1K | -2% | -$37.6K | |
| D | 2022-01-31 | 2022-01-28 | IMVT | Levine Mark S. | CLO | A - Grant | $0.00 | +143.0K | 143.0K | New | $0 |
| D | 2022-01-12 | 2022-01-10 | IMVT | Torti Frank | Dir | A - Grant | $0.00 | +100.1K | 147.7K | +210% | $0 |
| D | 2022-01-12 | 2022-01-10 | IMVT | Pande Atul | Dir | A - Grant | $0.00 | +21.7K | 61.9K | +54% | $0 |
| D | 2022-01-12 | 2022-01-10 | IMVT | Hughes Douglas J. | Dir | A - Grant | $0.00 | +21.7K | 80.2K | +37% | $0 |
| D | 2022-01-12 | 2022-01-10 | IMVT | Fromkin Andrew J. | Dir | A - Grant | $0.00 | +21.7K | 67.4K | +48% | $0 |
| D | 2022-01-12 | 2022-01-10 | IMVT | MIGAUSKY GEORGE V | Dir | A - Grant | $0.00 | +21.7K | 88.9K | +32% | $0 |
| 2022-01-11 | 2022-01-07 | IMVT | Barnett Eva Renee | CFO | S - Sale | $7.25 | -30.0K | 172.5K | -15% | -$217.2K | |
| 2022-01-11 | 2022-01-07 | IMVT | Butchko Julia G. | Chief Dev, Tech. Off | S - Sale | $7.25 | -55.3K | 289.5K | -16% | -$401.1K | |
| 2022-01-11 | 2022-01-07 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $7.25 | -125.2K | 578.0K | -18% | -$907.4K | |
| 2022-01-07 | 2022-01-05 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $8.28 | -26.8K | 197.3K | -12% | -$222.0K | |
| D | 2021-11-09 | 2021-11-05 | IMVT | Macias William L. | Chief Medical Off | A - Grant | $0.00 | +112.1K | 224.2K | +100% | $0 |
| D | 2021-10-18 | 2021-10-15 | IMVT | Barnett Eva Renee | CFO | A - Grant | $0.00 | +143.0K | 202.5K | +240% | $0 |
| 2021-10-05 | 2021-10-04 | IMVT | Barnett Eva Renee | CFO | A - Grant | $0.00 | +59.5K | 59.5K | New | $0 | |
| 2021-08-30 | 2021-08-27 | IMVT | Hughes Douglas J. | Dir | P - Purchase | $8.24 | +18.2K | 58.4K | +45% | +$150.4K | |
| 2021-08-20 | 2021-08-20 | IMVT | MIGAUSKY GEORGE V | Dir | P - Purchase | $7.65 | +7,000 | 67.2K | +12% | +$53.5K | |
| I | 2021-08-16 | 2021-08-13 | IMVT | Pande Atul | Dir | P - Purchase | $7.98 | +5,000 | 45.2K | +12% | +$39.9K |
| 2021-08-11 | 2021-08-10 | IMVT | Fromkin Andrew J. | Dir | P - Purchase | $7.90 | +5,500 | 45.7K | +14% | +$43.5K | |
| 2021-08-04 | 2021-08-03 | IMVT | Butchko Julia G. | Chief Dev, Tech. Off | A - Grant | $0.00 | +285.3K | 344.8K | +480% | $0 | |
| 2021-08-04 | 2021-08-03 | IMVT | Salzmann Peter | CEO, Dir | A - Grant | $0.00 | +570.6K | 703.1K | +431% | $0 | |
| 2021-08-02 | 2021-08-02 | IMVT | Roivant Sciences Ltd. | 10% | J - Other | — | +17.02M | 73.39M | +30% | — |
Purchase Sale Sale after option exercise All abbreviations